Ｎｅｋｏ Ｐｈａｒｍａ株式会社
Tokyo, Japan
No invoice registration| Invoice registration | Not registered as a qualified invoice issuer |
|---|---|
| Type | Corporation |
| Registered name | Ｎｅｋｏ Ｐｈａｒｍａ株式会社 |
| Address | 東京都中央区 Chuo-ku, Tokyo, JAPAN |
| Corporate number | 8010001214854 |
| Corporate number assigned on | 2021-01-05 |
Corporate registry record
| Entity type | Kabushiki Kaisha (stock company) |
|---|---|
| Reading (furigana) | ネコファーマ |
| Reading (romaji) | Nekofama |
| English name (unofficial) | Neko Pharma K.K. |
| Postal code | 104-0045 |
Source: NTA Corporate Number Publication Site, refreshed daily.
Timeline — registry changes
| 2024-05-14 | Head-office address changed (Japan) |
|---|
Source: daily change files of the NTA Corporate Number Publication Site. Before 2023-08-16 only the latest change is known. All company events →
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2025–2025; total ¥21.4M).
| 2025 FY2024 | スタートアップ支援事業（うちディープテック・スタートアップの起業・経営人材確保等支援事業） ¥21.4M （経済産業省） 起業家人材の発掘・育成、伴走支援事業（NEP） |
|---|
Contract details (excerpt): 人材発掘・起業家育成事業（NEP） ¥21.4M・補助金等交付 · bidders 142
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
Doing due diligence on this supplier?
Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t8010001214854) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-21.
Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence